Erratum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients (Nature Communications (2015) 6 (7539) DOI: 10.1038/ncomms8539);Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

Nature Communications

Volumn 6, Issue , 2015, Pages

  Ziv, Elad ^a   Dean, Eric ^b   Hu, Donglei ^a   Martino, Alessandro ^c   Serie, Daniel ^d   Curtin, Karen ^e   Campa, Daniele ^c   Aftab, Blake ^a   Bracci, Paige ^a   Buda, Gabriele ^f   Zhao, Yi ^e   Caswell Jin, Jennifer ^a   Diasio, Robert ^g   Dumontet, Charles ^h   Dudziński, Marek ⁱ   Fejerman, Laura ^a   Greenberg, Alexandra ^j   Huntsman, Scott ^a   Jamroziak, Krzysztof ^k   Jurczyszyn, Artur ^l   Kumar, Shaji ^j   Atanackovic, Djordje ^e   Glenn, Martha ^e   Cannon Albright, Lisa A ^e   Jones, Brandt ^e   Lee, Adam ^g   Marques, Herlander ^m   Martin, Thomas ^a   Martinez Lopez, Joaquin ⁿ   Rajkumar, Vincent ^j   Sainz, Juan ^o,p   Vangsted, Annette Juul ^q   Wątek, Marzena ^r   Wolf, Jeffrey ^a   Slager, Susan ^s   Camp, Nicola J ^e   Canzian, Federico ^c   Vachon, Celine ^j   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sutter Medical Center of Santa Rosa   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL OF PISA   (Italy)

^g MAYO GRADUATE SCHOOL   (United States)

^h UNIVERSITÉ LYON 1   (France)

ⁱ Regional Hospital Rzeszow   (Poland)

^j MAYO CLINIC   (United States)

^k MEDICAL UNIVERSITY OF LODZ   (Poland)

^l UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^m UNIVERSITY OF MINHO   (Portugal)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o UNIVERSITY OF GRANADA   (Spain)

^p HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^q UNIVERSITY OF COPENHAGEN   (Denmark)

^r Holycross Cancer Center   (Poland)

^s Mayo Clinic College of Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CHROMOSOME; COHORT ANALYSIS; GENE EXPRESSION; GENOME; HEALTH RISK; META-ANALYSIS; POLYMORPHISM; SOCIAL THEORY; SURVIVAL; TUMOR;

ARTICLE; CANCER SURVIVAL; CENTROSOME; CHROMOSOME 16P; CHROMOSOME VARIANT; CONTROLLED STUDY; FOPNL GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTIPLE MYELOMA; OVERALL SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 16; GENETICS; GENOME-WIDE ASSOCIATION STUDY; KAPLAN MEIER METHOD;

UNITED STATES; UTAH;

CHROMOSOMES, HUMAN, PAIR 16; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KAPLAN-MEIER ESTIMATE; MULTIPLE MYELOMA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84937850309     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10203     Document Type: Erratum

References (45)

1. Howlader, N. et al. SEER Cancer Statistics Review, 1975-2010 (National Cancer Institute, 2010).
2. Greenberg, A. J., Rajkumar, S. V. & Vachon, C. M. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood 119, 5359-5366 (2012).
3. Chubb, D. et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat. Genet. 45, 1221-1225 (2013).
4. Weinhold, N. et al. The CCND1 c.870G4A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat. Genet. 45, 522-525 (2013).
5. Broderick, P. et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat. Genet. 44, 58-61 (2012).
6. Rajkumar, S. V. & Greipp, P. R. Prognostic factors in multiple myeloma. Hematology 13, 1295-1314 (1999).
7. Kumar, S. et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood 119, 2100-2105 (2012).
8. Fonseca, R. et al. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma. Leukemia 20, 2034-2040 (2006).
9. Fonseca, R. et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101, 4569-4575 (2003).
10. Zhan, F. et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 109, 1692-1700 (2007).
11. Zhan, F., Barlogie, B., Mulligan, G., Shaughnessy, J. D. Jr., & Bryant, B. High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone. Blood 111, 968-969 (2008).
12. Zhan, F. et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 99, 1745-1757 (2002).
13. Zhan, F. et al. The molecular classification of multiple myeloma. Blood 108, 2020-2028 (2006).
14. Zhan, F. et al. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood 101, 1128-1140 (2003).
15. Wu, C. et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat. Genet. 45, 632-638 (2013).
16. Kiyotani, K. et al. A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese. Hum. Mol. Genet. 21, 1665-1672 (2012).
17. Shu, X. O. et al. Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res. 72, 1182-1189 (2012).
18. Innocenti, F. et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin. Cancer Res. 18, 577-584 (2012).
19. Wu, C. et al. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut. 63, 152-160 (2012).
20. Wu, C. et al. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients. Cancer Res. 70, 9721-9729 (2010).
21. Yang, T. P. et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26, 2474-2476 (2010).
22. Grundberg, E. et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
23. Aubusson-Fleury, A. et al. The conserved centrosomal protein FOR20 is required for assembly of the transition zone and basal body docking at the cell surface. J. Cell Sci. 125, 4395-4404 (2012).
24. Sedjai, F. et al. Control of ciliogenesis by FOR20, a novel centrosome and pericentriolar satellite protein. J. Cell Sci. 123, 2391-2401 (2010).
25. Chng, W. J. et al. The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition. Blood 111, 1603-1609 (2008).
26. Chng, W. J. et al. Clinical implication of centrosome amplification in plasma cell neoplasm. Blood 107, 3669-3675 (2006).
27. Raab, M. S. et al. GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo. Cancer Res. 72, 5374-5385 (2012).
28. Shiheido, H. et al. A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS ONE 7, e38878 (2012).
29. Zollner, S. & Pritchard, J. K. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am. J. Hum. Genet. 80, 605-615 (2007).
30. Stewart, D. A. et al. Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose. Bone Marrow Transplant. 23, 1237-1243 (1999).
31. Stewart, D. A. et al. The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose. Bone Marrow Transplant. 25, 435-440 (2000).
32. Martino, A. et al. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int. J. Oncol. 40, 625-638 (2012).
33. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br. J. Haematol. 121, 749-757 (2003).
34. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
35. Genomes Project C et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
36. Browning, B. L. & Browning, S. R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84, 210-223 (2009).
37. Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
38. Grambsch, P. A. & Therneau, T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515-526 (1994).
39. Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
40. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
41. Broyl, A. et al. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood 116, 2543-2553 (2010).
42. Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467-472 (2011).
43. Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40, W452-W457 (2012).
44. Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. Chapter 7, Unit 7-20 (2013).
45. Coetzee, S. G., Rhie, S. K., Berman, B. P., Coetzee, G. A. & Noushmehr, H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res. 40, e139 (2012).